The Society for Health Care Strategy & Market Development (SHSMD) of the American Hospital Association (AHA) released Futurescan 2020-2025: Health Care Trends and Implications, a highly respected report developed jointly with the American College of Healthcare Executives (ACHE).
AHA Press Releases
Below are the most recent press releases from the American Hospital Association.
Latest
Rick Pollack, President and CEO at the American Hospital Association (AHA), and Mark Parkinson, President and CEO at the American Health Care Association (AHCA), issued a joint statement in response to the Centers for Medicare & Medicaid Services’ (CMS) proposed Medicaid Fiscal Accountability Regulation.
The AHA announced Cody Regional Health (CRH) in Cody, Wyo. as the 2019 recipient of the Rural Hospital Leadership Award.
AHA released a statement on the surgical gowns and packs impacted by the Cardinal Health recall.
Because of the Affordable Care Act, 20 million people have health insurance, millions with pre-existing conditions have access to the care they need and new and innovative models of care have been launched.
The American Hospital Association’s Institute for Diversity and Health Equity (IFDHE) and Blue Cross and Blue Shield of Illinois (BCBSIL) today announced a joint collaboration and one-year grant program to support hospitals in eliminating health care disparities and working toward ensuring individuals in every community receive safe, equitable and high-quality care.
The AHA is pleased that at our urging, CMS will be repaying affected hospitals the full OPPS rate for 2019 to support the critical work they do for the patients and communities they serve.
America’s hospitals and health systems remain committed to protecting patients from unanticipated medical bills that they may incur because of gaps in their insurance coverage or as a result of emergencies.
America’s hospitals and health systems are committed to protecting patients from unanticipated medical bills that they may incur because of gaps in their insurance coverage or as a result of emergencies. Unfortunately, unless this proposal is much improved over previous bills that rely on a benchmark rate, it remains highly problematic and would jeopardize patient access to hospital care, particularly in rural communities.
Today, four national organizations representing hospitals and health systems sued the federal government, challenging last month’s contract disclosure rule from the Centers for Medicare & Medicaid Services (CMS).
Twenty years ago, the Institute of Medicine issued a call to action and the women and men of America’s hospitals and health systems responded by working tirelessly to make health care better, safer and more patient-centered. Due to the efforts of hospital and health system leaders, trustees, caregivers on the front lines and all of the other dedicated employees ensuring safe and caring environments, our field has improved the safety and quality of care, delivering real progress that has benefited patients.
The American Hospital Association (AHA), Association of American Medical Colleges (AAMC), Children’s Hospital Association (CHA) and Federation of American Hospitals (FAH) issued the following joint statement on today’s final rule from CMS: Today’s rule mandating the public disclosure of privately negotiated rates between commercial health insurance companies and hospitals is a setback in efforts to provide patients with the most relevant information they need to make informed decisions about their care.
WASHINGTON
The field has lost a giant in health care. Bernard Tyson was a champion for creating a more integrated and coordinated delivery system, and expanding coverage and access.
Today’s final rule from CMS regrettably ignores recent legal decisions while also putting even more pressure on hospitals and health systems that care for vulnerable patients and communities.
The AHA welcomes the nomination of Dr. Stephen Hahn, a renowned oncologist and physician leader, to be the next commissioner of the Food and Drug Administration. As the chief medical executive at The University of Texas MD Anderson Cancer Center, Dr. Hahn leads the medical practice at one of the world’s top hospitals devoted to cancer care, research, education and prevention. We believe that Dr. Hahn’s more than 20 years of experience on the front lines of delivering patient care, overseeing clinical research and operations, and quality and safety initiatives makes him a uniquely qualified nominee to lead the FDA.